The market for animal pharmaceuticals market is likely to grow with a steady CAGR during the forecast period due to the increase in pet adoption, rise in fatal diseases like Ebola and swine flu spreading from consumption of dairy and animal related products. Animal pharmaceuticals are highly beneficial in diagnosis and treatment of animal disorders. The restraining factors for the market can be the government rules regarding animal testing, and the probability of sales of fake medicines across e-commerce platforms. 

The global animal pharmaceuticals market is segmented on the basis of product type, product, animal type, registration and region. Based on animal type, the market is segmented into companion and production animals. Companion animals tend to hold a larger share in the market as pet owners are concerned for their pet’s health and well-being. As compared to production animals, companion animals receive special care and veterinary treatment from their owners, which is the major factor driving the market share of this segment. 

The overall animal pharmaceuticals market is widespread, expanding itself to Asia-Pacific, Europe, North America, South America, and Middle East & Africa. North America holds the largest market share by virtue of the pre-existing established pharmaceutical companies and the increasing consumption of meat and milk in the region. However, fastest growth is shown by the Asia-Pacific sector due to export of animals to other countries. Export process involves testing of the animals with which farm owners need to comply with therefore, the region is expected to witness highest growth over the next five years. 

Major players of the animal pharmaceuticals market include Zoetis Inc, Merck Animal Health, Vetoquinol SA, Zoetis Inc, Virbac SA, Boehringer Ingelheim International GmbH, Eli Lilly & Co, Perrigo Co PLC, Sanofi SA, Bayer AG, Elanco Animal Health Inc, Ceva Sante Animale S.A., Covetrus Inc., Idexx Laboratories Inc., Vetoquinol USA, Inc., Norbrook Laboratories, Ltd., Huvepharma EOOD, Adivo GmbH, Ceva Sant Animale, Phibro Animal Health Corp, etc. The inter-company competition keeps on increasing parallelly with the market which in turn leads to innovations in technology, thus enhancing animal healthcare sector.

Years considered for this report:

Historical Years: 2015-2018

Base Year: 2019

Estimated Year: 2020

Forecast Period: 2021–2025

Objective of the Study:

  • To analyze and forecast the market size of global animal pharmaceuticals market.
  • To classify and forecast global animal pharmaceuticals market based on product type, product, animal type, registration and region.
  • To identify drivers and challenges for global animal pharmaceuticals market.
  • To examine competitive developments such as expansions, new product launches, mergers & acquisitions, etc., in global animal pharmaceuticals market.
  • To conduct pricing analysis for global animal pharmaceuticals market.
  • To identify and analyze the profile of leading players operating in global animal pharmaceuticals market.


Click here to download the sample

TechSci Research performed both primary as well as exhaustive secondary research for this study. Initially, TechSci Research sourced a list of manufacturers across the globe. Subsequently, TechSci Research conducted primary research surveys with the identified companies. While interviewing, the respondents were also enquired about their competitors. Through this technique, TechSci Research could include the manufacturers which could not be identified due to the limitations of secondary research. TechSci Research analyzed the manufacturers, distribution channels and presence of all major players across the globe.

TechSci Research calculated the market size of global animal pharmaceuticals market using a bottom-up approach, wherein data for various end-user segments was recorded and forecast for the future years. TechSci Research sourced these values from the industry experts and company representatives and externally validated through analyzing historical data of these product types and applications for getting an appropriate, overall market size. Various secondary sources such as company websites, news articles, press releases, company annual reports, investor presentations and financial reports were also studied by TechSci Research.


Key Target Audience:

  • Manufacturers, suppliers of medicines, distributors and other stakeholders
  • Animal healthcare centers, vets
  • Government bodies such as regulating authorities and policy makers
  • Organizations, forums and alliances related to animal pharmaceuticals
  • Market research and consulting firms

The study is useful in providing answers to several critical questions that are important for the industry stakeholders such as manufacturers, partners, end users, etc., besides allowing them in strategizing investments and capitalizing on market opportunities.

Report Scope:

In this report, global animal pharmaceuticals market has been segmented into following categories, in addition to the industry trends which have also been detailed below:

  • Market, By Product Type:
    • Vaccine
    • Veterinary
    • Others
  • Market, By Product:
    • Ectoparasiticides
      • Ivermectin
      • Cypermethrin
      • Fipronil
      • Coumaphos
      • Others
    • Endoparasiticides
      • Ivermectin
      • Praziquantel
      • Flubendazol
      • Milbemycin
      • Levamisole
      • Fenbendazole
      • Pyrantel
      • Others
    • Anti-Inflammatories
      • NSAIDs
      • Corticosteroids
      • Others
    • Bronchodilators
      • Theophylline
      • Albuterol
      • Others
  • Market, By Animal Type:
    • Companion Animals
    • Production Animals
  • Market, By Registration:
    • Generic
    • Patented
  • Market, By Region:
    • Asia-Pacific
      • China
      • India
      • Japan
      • South Korea
      • Australia
    • Europe
      • United Kingdom
      • Italy
      • France
      • Germany
      • Spain
    • North America
      • United States
      • Canada
      • Mexico
    • South America
      • Brazil
      • Argentina
      • Colombia
    • Middle East & Africa
      • UAE
      • Saudi Arabia
      • Qatar
      • South Africa

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in global animal pharmaceuticals market.

Available Customizations:

With the given market data, TechSci Research offers customizations according to a company’s specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).
It is an upcoming report to be released soon. If you wish an early delivery of this report or want to confirm the date of release, please contact us at sales@techsciresearch.com

In case you don’t find what you are looking for, please get in touch with our custom research team at sales@techsciresearch.com

1.    Product Overview

2.    Research Methodology

3.    Executive Summary

4.    Voice of Customers

5.    Global Animal Pharmaceuticals Market Outlook

5.1.  Market Size & Forecast

5.1.1.     By Value & Volume

5.2.  Market Share & Forecast

5.2.1.     By Product Type (Vaccine, Veterinary, Others)

5.2.2.     By Product

5.2.2.1.         Ectoparasiticides (Ivermectin, Cypermethrin, Fipronil, Coumaphos, Others)

5.2.2.2.         Endoparasiticides (Ivermectin, Praziquantel, Flubendazole, Milbemycin, Levamisole, Fenbendazole, Pyrantel, Others)

5.2.2.3.         Anti-Inflammatories (NSAIDs, Corticosteroids, Others)

5.2.2.4.         Bronchodilators (Theophylline, Albuterol, Others)

5.2.3.     By Animal Type (Companion Animals, Production Animals)

5.2.4.     By Registration (Generic, Patented)

5.2.5.     By Region (Asia-Pacific, Europe, North America, South America, MEA)

5.2.6.     By Company (2019)

5.3.  Product Market Map

6.    Asia-Pacific Animal Pharmaceuticals Market Outlook

6.1.  Market Size & Forecast

6.1.1.     By Value & Volume

6.2.  Market Share & Forecast

6.2.1.     By Product Type

6.2.2.     By Product

6.2.3.     By Animal Type

6.2.4.     By Country (China; India; Japan; South Korea; Australia)

6.3.  Asia-Pacific: Country Analysis

6.3.1.     China Animal Pharmaceuticals Market Outlook

6.3.1.1.         Market Size & Forecast

6.3.1.1.1.             By Value & Volume

6.3.1.2.         Market Share & Forecast

6.3.1.2.1.             By Product Type

6.3.1.2.2.             By Product

6.3.1.2.3.             By Animal Type

6.3.2.     India Animal Pharmaceuticals Market Outlook

6.3.2.1.         Market Size & Forecast

6.3.2.1.1.             By Value & Volume

6.3.2.2.         Market Share & Forecast

6.3.2.2.1.             By Product Type

6.3.2.2.2.             By Product

6.3.2.2.3.             By Animal Type

6.3.3.     Japan Animal Pharmaceuticals Market Outlook

6.3.3.1.         Market Size & Forecast

6.3.3.1.1.             By Value & Volume

6.3.3.2.         Market Share & Forecast

6.3.3.2.1.             By Product Type

6.3.3.2.2.             By Product

6.3.3.2.3.             By Animal Type

6.3.4.     South Korea Animal Pharmaceuticals Market Outlook

6.3.4.1.         Market Size & Forecast

6.3.4.1.1.             By Value & Volume

6.3.4.2.         Market Share & Forecast

6.3.4.2.1.             By Product Type

6.3.4.2.2.             By Product

6.3.4.2.3.             By Animal Type

6.3.5.     Australia Animal Pharmaceuticals Market Outlook

6.3.5.1.         Market Size & Forecast

6.3.5.1.1.             By Value & Volume

6.3.5.2.         Market Share & Forecast

6.3.5.2.1.             By Product Type

6.3.5.2.2.             By Product

6.3.5.2.3.             By Animal Type

7.    Europe Animal Pharmaceuticals Market Outlook

7.1.  Market Size & Forecast          

7.1.1.     By Value & Volume

7.2.  Market Share & Forecast

7.2.1.     By Product Type

7.2.2.     By Product

7.2.3.     By Animal Type

7.2.4.     By Country (United Kingdom; Italy; France; Germany; Spain)

7.3.  Europe: Country Analysis

7.3.1.     United Kingdom Animal Pharmaceuticals Market Outlook

7.3.1.1.         Market Size & Forecast

7.3.1.1.1.             By Value & Volume

7.3.1.2.         Market Share & Forecast

7.3.1.2.1.             By Product Type

7.3.1.2.2.             By Product

7.3.1.2.3.             By Animal Type

7.3.2.     Italy Animal Pharmaceuticals Market Outlook

7.3.2.1.         Market Size & Forecast

7.3.2.1.1.             By Value & Volume

7.3.2.2.         Market Share & Forecast

7.3.2.2.1.             By Product Type

7.3.2.2.2.             By Product

7.3.2.2.3.             By Animal Type

7.3.3.     France Animal Pharmaceuticals Market Outlook

7.3.3.1.         Market Size & Forecast

7.3.3.1.1.             By Value & Volume

7.3.3.2.         Market Share & Forecast

7.3.3.2.1.             By Product Type

7.3.3.2.2.             By Product

7.3.3.2.3.             By Animal Type

7.3.4.     Germany Animal Pharmaceuticals Market Outlook

7.3.4.1.         Market Size & Forecast

7.3.4.1.1.             By Value & Volume

7.3.4.2.         Market Share & Forecast

7.3.4.2.1.             By Product Type

7.3.4.2.2.             By Product

7.3.4.2.3.             By Animal Type

7.3.5.     Spain Animal Pharmaceuticals Market Outlook

7.3.5.1.         Market Size & Forecast

7.3.5.1.1.             By Value & Volume

7.3.5.2.         Market Share & Forecast

7.3.5.2.1.             By Product Type

7.3.5.2.2.             By Product

7.3.5.2.3.             By Animal Type

8.    North America Animal Pharmaceuticals Market Outlook

8.1.  Market Size & Forecast          

8.1.1.     By Value & Volume

8.2.  Market Share & Forecast

8.2.1.     By Product Type

8.2.2.     By Product

8.2.3.     By Animal Type

8.2.4.     By Country (United States, Canada, Mexico)

8.3.  North America: Country Analysis

8.3.1.     United States Animal Pharmaceuticals Market Outlook

8.3.1.1.         Market Size & Forecast

8.3.1.1.1.             By Value & Volume

8.3.1.2.         Market Share & Forecast

8.3.1.2.1.             By Product Type

8.3.1.2.2.             By Product

8.3.1.2.3.             By Animal Type

8.3.2.     Canada Animal Pharmaceuticals Market Outlook

8.3.2.1.         Market Size & Forecast

8.3.2.1.1.             By Value & Volume

8.3.2.2.         Market Share & Forecast

8.3.2.2.1.             By Product Type

8.3.2.2.2.             By Product

8.3.2.2.3.             By Animal Type

8.3.3.     Mexico Animal Pharmaceuticals Market Outlook

8.3.3.1.         Market Size & Forecast

8.3.3.1.1.             By Value & Volume

8.3.3.2.         Market Share & Forecast

8.3.3.2.1.             By Product Type

8.3.3.2.2.             By Product

8.3.3.2.3.             By Animal Type

9.    South America Animal Pharmaceuticals Market Outlook

9.1.  Market Size & Forecast          

9.1.1.     By Value & Volume

9.2.  Market Share & Forecast

9.2.1.     By Product Type

9.2.2.     By Product

9.2.3.     By Animal Type

9.2.4.     By Country (Brazil, Argentina, Colombia)

9.3.  South America: Country Analysis

9.3.1.     Brazil Animal Pharmaceuticals Market Outlook

9.3.1.1.         Market Size & Forecast

9.3.1.1.1.             By Value & Volume

9.3.1.2.         Market Share & Forecast

9.3.1.2.1.             By Product Type

9.3.1.2.2.             By Product

9.3.1.2.3.             By Animal Type

9.3.2.     Argentina Animal Pharmaceuticals Market Outlook

9.3.2.1.         Market Size & Forecast

9.3.2.1.1.             By Value & Volume

9.3.2.2.         Market Share & Forecast

9.3.2.2.1.             By Product Type

9.3.2.2.2.             By Product

9.3.2.2.3.             By Animal Type

9.3.3.     Colombia Animal Pharmaceuticals Market Outlook

9.3.3.1.         Market Size & Forecast

9.3.3.1.1.             By Value & Volume

9.3.3.2.         Market Share & Forecast

9.3.3.2.1.             By Product Type

9.3.3.2.2.             By Product

9.3.3.2.3.             By Animal Type

10.  Middle East and Africa (MEA) Animal Pharmaceuticals Market Outlook

10.1.              Market Size & Forecast

10.1.1.  By Value & Volume

10.2.              Market Share & Forecast

10.2.1.  By Product Type

10.2.2.  By Product

10.2.3.  By Animal Type

10.2.4.  By Country (UAE; Saudi Arabia; Qatar, South Africa)

10.3.              Middle East and Africa (MEA): Country Analysis

10.3.1.  UAE Animal Pharmaceuticals Market Outlook

10.3.1.1.      Market Size & Forecast

10.3.1.1.1.           By Value & Volume

10.3.1.2.      Market Share & Forecast

10.3.1.2.1.           By Product Type

10.3.1.2.2.           By Product

10.3.1.2.3.           By Animal Type

10.3.2.  Saudi Arabia Animal Pharmaceuticals Market Outlook

10.3.2.1.      Market Size & Forecast

10.3.2.1.1.           By Value & Volume

10.3.2.2.      Market Share & Forecast

10.3.2.2.1.           By Product Type

10.3.2.2.2.           By Product

10.3.2.2.3.           By Animal Type

10.3.3.  Qatar Animal Pharmaceuticals Market Outlook

10.3.3.1.      Market Size & Forecast

10.3.3.1.1.           By Value & Volume

10.3.3.2.      Market Share & Forecast

10.3.3.2.1.           By Product Type

10.3.3.2.2.           By Product

10.3.3.2.3.           By Animal Type

10.3.4.  South Africa Animal Pharmaceuticals Market Outlook

10.3.4.1.      Market Size & Forecast

10.3.4.1.1.           By Value & Volume

10.3.4.2.      Market Share & Forecast

10.3.4.2.1.           By Product Type

10.3.4.2.2.           By Product

10.3.4.2.3.           By Animal Type

11.  Market Dynamics

11.1.              Drivers

11.2.              Challenges

12.  Market Trends & Developments

13.  Pricing Analysis

14.  Patent / FDA Approval Analysis

14.1.              New Product Development (NADA, ANADA, CNADA)

14.2.              By Company

14.3.              Registration Date

14.4.              Patent Expiry

15.  Competitive Landscape

15.1.              Company Profiles (Leading Companies)

15.1.1.  Zoetis Inc

15.1.2.  Merck Animal Health

15.1.3.  Vetoquinol SA

15.1.4.  Zoetis Inc

15.1.5.  Virbac SA

15.1.6.  Boehringer Ingelheim International GmbH

15.1.7.  Eli Lilly & Co

15.1.8.  Perrigo Co PLC

15.1.9.  Sanofi SA

15.1.10.                Bayer AG

15.1.11.                Elanco Animal Health Inc

15.1.12.                Ceva Sante Animale S.A.

15.1.13.                Covetrus Inc.

15.1.14.                Idexx Laboratories Inc.

15.1.15.                Vetoquinol USA, Inc.

15.1.16.                Norbrook Laboratories, Ltd.

15.1.17.                Huvepharma EOOD

15.1.18.                Adivo GmbH

15.1.19.                Ceva Sant Animale

15.1.20.                Phibro Animal Health Corp.

16.  Strategic Recommendations

About Us & Disclaimer

In case you don’t find what you are looking for, please get in touch with our custom research team at sales@techsciresearch.com